東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Identification of distinct gene expr...

Graham, Kelly A.

FindBook

Google Book

Amazon

博客來

Identification of distinct gene expression signatures in histologically normal epithelium from patients with different breast cancer risk.

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Identification of distinct gene expression signatures in histologically normal epithelium from patients with different breast cancer risk./
作者:	Graham, Kelly A.
面頁冊數:	204 p.
附註:	Source: Dissertation Abstracts International, Volume: 71-03, Section: B, page: 1468.
Contained By:	Dissertation Abstracts International71-03B.
標題:	Biology, Genetics. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3399487
ISBN:	9781109655421

Identification of distinct gene expression signatures in histologically normal epithelium from patients with different breast cancer risk.
Graham, Kelly A.

Identification of distinct gene expression signatures in histologically normal epithelium from patients with different breast cancer risk. - 204 p.

Source: Dissertation Abstracts International, Volume: 71-03, Section: B, page: 1468.

Thesis (Ph.D.)--Boston University, 2010.

Genomic alterations exist before histological evidence of malignancy, yet cancer precursors are seriously understudied. Investigating these precursors would help elucidate the features of breast cancer initiation and progression. We hypothesized that the gene expression in histologically normal epithelium from breast cancer patients (HN) would differ from gene expression in histologically normal epithelium from reduction mammoplasty controls (RM). We found the gene expression profiles were different in the two tissues; genes downregulated in HN include MAPK pathway components as well as transcription factors ( ATF3, ETS2, MAFF, and TXNIP).

ISBN: 9781109655421Subjects--Topical Terms:

1017730
Biology, Genetics.

Identification of distinct gene expression signatures in histologically normal epithelium from patients with different breast cancer risk.
LDR:03580nam 2200325 4500 001 1403508
005 20111118095943.5
008 130515s2010 ||||||||||||||||| ||eng d
020 $a 9781109655421
035 $a (UMI)AAI3399487
035 $a AAI3399487
040 $a UMI $c UMI
100 1 $a Graham, Kelly A. $3 1682772
245 1 0 $a Identification of distinct gene expression signatures in histologically normal epithelium from patients with different breast cancer risk.
300 $a 204 p.
500 $a Source: Dissertation Abstracts International, Volume: 71-03, Section: B, page: 1468.
500 $a Adviser: Carol L. Rosenberg.
502 $a Thesis (Ph.D.)--Boston University, 2010.
520 $a Genomic alterations exist before histological evidence of malignancy, yet cancer precursors are seriously understudied. Investigating these precursors would help elucidate the features of breast cancer initiation and progression. We hypothesized that the gene expression in histologically normal epithelium from breast cancer patients (HN) would differ from gene expression in histologically normal epithelium from reduction mammoplasty controls (RM). We found the gene expression profiles were different in the two tissues; genes downregulated in HN include MAPK pathway components as well as transcription factors ( ATF3, ETS2, MAFF, and TXNIP).
520 $a There are no studies of comprehensive gene expression in prophylactic mastectomy samples, although their clinical characteristics are well-studied. Knowledge of gene expression changes in these tissues could be integrated into existing risk-assessment models, improving their accuracy. We hypothesized gene expression in histologically normal epithelium of women at high breast cancer risk, undergoing prophylactic mastectomy (PM), would show greater similarity to HN samples than RM samples. We found the PM expression profile is more similar to HN samples than RM samples, with the exception of the genes in the MAPK pathway, which had a more similar expression signature to RMs than HNs.
520 $a Breast cancer is a heterogeneous disease whose origin is unclear. Many studies have sought to define the transcriptome of tumors and classify them based on their gene expression. To date, few studies have focused on gene expression profiles in the histologically normal epithelium from women with breast cancer. Studying the earliest divergent features in ER+ and ER- breast cancer patients will help to develop more tailored therapies for specific types of the disease. We hypothesized there are differences in gene expression between histologically normal epithelium from ER+ and ER- breast cancer patients. We found that pathways implicated in ER+ carcinogenesis (the ESR and GATA3 Pathways) were present in histologically normal epithelium from ER+ patients, while immune response genes composed 32% of genes with a higher expression in histologically normal epithelium from ER- patients.
520 $a The gene expression differences identified between the samples demonstrate identification of distinct early changes in breast carcinogenesis in specific patient populations. Identification of these early changes will help to accurately determine risk and develop more specific agents for breast cancer treatment and prevention.
590 $a School code: 0017.
650 4 $a Biology, Genetics. $3 1017730
650 4 $a Health Sciences, Pathology. $3 1017854
650 4 $a Health Sciences, Oncology. $3 1018566
690 $a 0369
690 $a 0571
690 $a 0992
710 2 $a Boston University. $3 1017454
773 0 $t Dissertation Abstracts International $g 71-03B.
790 1 0 $a Rosenberg, Carol L., $e advisor
790 $a 0017
791 $a Ph.D.
792 $a 2010
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3399487